Overview

Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of cyclosporine ophthalmic emulsion administered twice daily following LASIK surgery
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Cyclosporine
Cyclosporins
Lubricant Eye Drops